相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic effect of cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma: a comparative study using inverse probability of treatment weighting
Tobias Klatte et al.
WORLD JOURNAL OF UROLOGY (2018)
Immune Biomarkers Predictive for Disease-Free Survival with Adjuvant Sunitinib in High-Risk Locoregional Renal Cell Carcinoma: From Randomized Phase III S-TRAC Study
Daniel J. George et al.
CLINICAL CANCER RESEARCH (2018)
Predicting Oncologic Outcomes in Renal Cell Carcinoma After Surgery
Bradley C. Leibovich et al.
EUROPEAN UROLOGY (2018)
Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma
Diana Miao et al.
SCIENCE (2018)
Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice
Jens Bedke et al.
BJU INTERNATIONAL (2018)
Vimentin over-expression and carbonic anhydrase IX under-expression are independent predictors of recurrence, specific and overall survival in non-metastatic clear-cell renal carcinoma: a validation study
A. Ingels et al.
WORLD JOURNAL OF UROLOGY (2017)
Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients
Hong Hu et al.
WORLD JOURNAL OF UROLOGY (2017)
Prognostic value of the Glasgow Prognostic Score in renal cell carcinoma: a meta-analysis
Sung Ryul Shim et al.
WORLD JOURNAL OF UROLOGY (2017)
Application of the Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear Cell Renal Cell Carcinoma in Contemporary Patients
William P. Parker et al.
EUROPEAN UROLOGY (2017)
Updated European Association of Urology Guidelines Regarding Adjuvant Therapy for Renal Cell Carcinoma
Axel Bex et al.
EUROPEAN UROLOGY (2017)
Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model
Guillermo de Velasco et al.
ONCOLOGIST (2017)
Protocol for a multicentre randomised feasibility STUdy evaluating the impact of a prognostic model for Management of BLunt chest wall trauma patients: STUMBL trial
Ceri Battle et al.
BMJ OPEN (2017)
Recognizing the Continuous Nature of Expression Heterogeneity and Clinical Outcomes in Clear Cell Renal Cell Carcinoma
Xiaona Wei et al.
SCIENTIFIC REPORTS (2017)
Histologic subtype impacts cancer-specific survival in patients with sarcomatoid-variant renal cell carcinoma treated surgically
Daniel P. Nguyen et al.
WORLD JOURNAL OF UROLOGY (2016)
The subclassification of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery
Pierre Bigot et al.
WORLD JOURNAL OF UROLOGY (2016)
Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgery
Rodrigo A. Ledezma et al.
WORLD JOURNAL OF UROLOGY (2016)
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours
Holger Moch et al.
EUROPEAN UROLOGY (2016)
The Prognostic Impact of a Positive Vascular Margin on pT3 Clear Cell Renal Cell Carcinoma
Nick W. Liu et al.
JOURNAL OF UROLOGY (2016)
Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial
Naomi B. Haas et al.
LANCET (2016)
A prospective risk-stratified follow-up programme for radically treated renal cell carcinoma patients: evaluation after eight years of clinical use
Christian Beisland et al.
WORLD JOURNAL OF UROLOGY (2016)
Paraneoplastic syndromes are associated with adverse prognosis among patients with renal cell carcinoma undergoing nephrectomy
Daniel M. Moreira et al.
WORLD JOURNAL OF UROLOGY (2016)
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
Borje Ljungberg et al.
EUROPEAN UROLOGY (2015)
Clinicopathological and immunohistochemical characteristics of papillary renal cell carcinoma with emphasis on subtyping
Ahmed K. Alomari et al.
HUMAN PATHOLOGY (2015)
Biomarker: Predictive or Prognostic?
Karla V. Ballman
JOURNAL OF CLINICAL ONCOLOGY (2015)
A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies
Brian Rini et al.
LANCET ONCOLOGY (2015)
International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study
Jenny J. Ko et al.
LANCET ONCOLOGY (2015)
Comparison of the prognostic value of pretreatment measurements of systemic inflammatory response in patients undergoing curative resection of clear cell renal cell carcinoma
Ilaria Lucca et al.
WORLD JOURNAL OF UROLOGY (2015)
Preoperative serum cholesterol is an independent prognostic factor for patients with renal cell carcinoma (RCC)
Michela de Martino et al.
BJU INTERNATIONAL (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Pretherapeutic gamma-glutamyltransferase is an independent prognostic factor for patients with renal cell carcinoma
S. L. Hofbauer et al.
BRITISH JOURNAL OF CANCER (2014)
Loss of BAP1 Protein Expression Is an Independent Marker of Poor Prognosis in Patients With Low-Risk Clear Cell Renal Cell Carcinoma
Richard W. Joseph et al.
CANCER (2014)
Carbonic Anhydrase 9 Expression Increases with Vascular Endothelial Growth Factor-Targeted Therapy and Is Predictive of Outcome in Metastatic Clear Cell Renal Cancer
Grant D. Stewart et al.
EUROPEAN UROLOGY (2014)
Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
Daniel Y. C. Heng et al.
EUROPEAN UROLOGY (2014)
ClearCode34: A Prognostic Risk Predictor for Localized Clear Cell Renal Cell Carcinoma
Samira A. Brooks et al.
EUROPEAN UROLOGY (2014)
The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters
Brett Delahunt et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
Validation of serum C-reactive protein (CRP) as an independent prognostic factor for disease-free survival in patients with localised renal cell carcinoma (RCC)
Michela de Martino et al.
BJU INTERNATIONAL (2013)
Validation of the pre-treatment neutrophil lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients
M. Pichler et al.
BRITISH JOURNAL OF CANCER (2013)
Positive Surgical Margins After Nephron-Sparing Surgery for Renal Cell Carcinoma: Incidence, Clinical Impact, and Management
Marco Borghesi et al.
CLINICAL GENITOURINARY CANCER (2013)
The Protease Activated Receptor 1 Gene Variation IVSn-14 A > T is Associated with Distant Metastasis and Cancer Specific Survival in Renal Cell Carcinoma
Michela de Martino et al.
JOURNAL OF UROLOGY (2013)
A prognostic model for metastatic renal-cell carcinoma
Matthew D. Galsky
LANCET ONCOLOGY (2013)
External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study
Daniel Y. C. Heng et al.
LANCET ONCOLOGY (2013)
Prognosis Research Strategy (PROGRESS) 3: Prognostic Model Research
Ewout W. Steyerberg et al.
PLOS MEDICINE (2013)
Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma
S. H. Sim et al.
BRITISH JOURNAL OF CANCER (2012)
Histopathology of Surgically Treated Renal Cell Carcinoma: Survival Differences by Subtype and Stage
Kirk A. Keegan et al.
JOURNAL OF UROLOGY (2012)
Prognostic factors for progression-free and overall survival with sunitinib targeted therapy and with cytokine as first-line therapy in patients with metastatic renal cell carcinoma
S. Patil et al.
ANNALS OF ONCOLOGY (2011)
Prognostic Model for Survival in Patients with Metastatic Renal Cell Carcinoma: Results from the International Kidney Cancer Working Group
Judith Manola et al.
CLINICAL CANCER RESEARCH (2011)
Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary Review
Maxine Sun et al.
EUROPEAN UROLOGY (2011)
Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines
S. Mallett et al.
BRITISH JOURNAL OF CANCER (2010)
Can We Better Select Patients With Metastatic Renal Cell Carcinoma for Cytoreductive Nephrectomy?
Stephen H. Culp et al.
CANCER (2010)
Comparison of the UCLA Integrated Staging System and the Leibovich Score in Survival Prediction for Patients With Nonmetastatic Clear Cell Renal Cell Carcinoma
Min-Han Tan et al.
UROLOGY (2010)
Everything You Always Wanted to Know About Evaluating Prediction Models (But Were Too Afraid to Ask)
Andrew J. Vickers et al.
UROLOGY (2010)
Advanced-stage renal cell carcinoma treated by radical nephrectomy and adjacent organ or structure resection
Michael E. Karellas et al.
BJU INTERNATIONAL (2009)
Molecular Signatures of Localized Clear Cell Renal Cell Carcinoma to Predict Disease-Free Survival after Nephrectomy
Tobias Klatte et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Cytogenetic and Molecular Tumor Profiling for Type 1 and Type 2 Papillary Renal Cell Carcinoma
Tobias Klatte et al.
CLINICAL CANCER RESEARCH (2009)
A Proposal for Reclassification of the Fuhrman Grading System in Patients with Clear Cell Renal Cell Carcinoma
Maxine Sun et al.
EUROPEAN UROLOGY (2009)
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor-Targeted Agents: Results From a Large, Multicenter Study
Daniel Y. C. Heng et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
Richard M. Simon et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Presence of Tumor Necrosis is Not a Significant Predictor of Survival in Clear Cell Renal Cell Carcinoma: Higher Prognostic Accuracy of Extent Based Rather Than Presence/Absence Classification
Tobias Klatte et al.
JOURNAL OF UROLOGY (2009)
Pathobiology and prognosis of chromophobe renal cell carcinoma
Tobias Klatte et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2008)
Hypoxia-inducible factor 1α in clear cell renal cell carcinoma
Tobias Klatte et al.
CLINICAL CANCER RESEARCH (2007)
Prognostic relevance of the mTOR pathway in renal cell carcinoma - Implications for molecular patient selection for targeted therapy
Allan J. Pantuck et al.
CANCER (2007)
Multi-institutional validation of a new renal cancer-specific survival nomogram
Pierre I. Karakiewicz et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Prognostic ability of simplified nuclear grading of renal cell carcinoma
Nathalie Rioux-Leclercq et al.
CANCER (2007)
Prognostic factors associated with long-term survival in previously untreated metastatic renal cell carcinoma
T. K. Choueiri et al.
ANNALS OF ONCOLOGY (2007)
REporting recommendations for tumour MARKer prognostic studies (REMARK)
LM McShane et al.
BRITISH JOURNAL OF CANCER (2005)
Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness
S Sengupta et al.
CANCER (2005)
Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system
JS Lam et al.
JOURNAL OF UROLOGY (2005)
Prognostic value of histologic subtypes in renal cell carcinoma:: A multicenter experience
JJ Patard et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Original and reviewed nuclear grading according to the Fuhrman system - A multivariate analysis of 388 patients with conventional renal cell carcinoma
V Ficarra et al.
CANCER (2005)
A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma
M Sorbellini et al.
JOURNAL OF UROLOGY (2005)
Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma - A stratification tool for prospective clinical trials
BC Leibovich et al.
CANCER (2003)
Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma
A Zisman et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: The SSIGN score
I Frank et al.
JOURNAL OF UROLOGY (2002)
Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines:: a report from the Groupe Francais d'Immunotherapie
S Négrier et al.
ANNALS OF ONCOLOGY (2002)
A postoperative prognostic nomogram for renal cell carcinoma
MW Kattan et al.
JOURNAL OF UROLOGY (2001)
分享论文
